MiniMed reported revenue of $843.00M for the quarter ended Jul 2026, up 22.7% year over year. This income statement covers 5 quarters of results from Jan 2025 through Jul 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jan2025 | Apr2025 | Jan2026 | Apr2026 | Jul2026 |
|---|---|---|---|---|---|
| Revenue & cost | |||||
| Revenue | 687.00M | 724.00M | 790.00M | 837.00M | 843.00M |
| Cost of RevenueCost of Rev | 292.00M | 318.00M | 428.00M | 357.00M | 378.00M |
| Gross Profit | 395.00M | 405.00M | 362.00M | 480.00M | 465.00M |
| Operating items | |||||
| Research & DevelopmentR&D | 112.00M | 107.00M | 114.00M | 99.00M | 115.00M |
| Selling, General & AdministrativeSG&A | 268.00M | 276.00M | 309.00M | 299.00M | 312.00M |
| Other Operating ExpensesOther Opex | 7.00M | -177.00M | -45.00M | -157.00M | -36.00M |
| Operating ExpensesOpex | 380.00M | 383.00M | 423.00M | 398.00M | 427.00M |
| Operating IncomeOp. Inc | 21.00M | -148.00M | -100.00M | -93.00M | 5.00M |
| EBIT | 21.00M | -148.00M | -100.00M | -93.00M | 5.00M |
| Non-operating items | |||||
| Other Non Operating IncomeOther Non Op Inc. | 1.00M | ||||
| Net income details | |||||
| EBT | 21.00M | -148.00M | -99.00M | -92.00M | 4.00M |
| Tax ProvisionsTaxes | 28.00M | 21.00M | 12.00M | 93.00M | 4.00M |
| Profit After TaxPAT | -10.00M | -172.00M | -119.00M | -185.00M | |
| Income from Non-Controlling InterestsInc. Minority | 3.00M | 5.00M | 8.00M | 5.00M | |
| Income from Continuing OperationsIncome (Continuing) | -7.00M | -169.00M | -111.00M | -185.00M | |
| Consolidated Net IncomeConsol Net Inc. | -7.00M | -169.00M | -111.00M | -185.00M | |
| Income towards Parent CompanyParent Net Inc | -7.00M | -169.00M | -111.00M | -185.00M | |
| Net Income towards Common StockholdersNet Income | -7.00M | -169.00M | -111.00M | -185.00M | |
| Additional items | |||||
| EPS (Basic) | -0.03 | -0.67 | -0.44 | -0.72 | |
| EPS (Diluted) | -0.03 | -0.67 | -0.44 | -0.72 | |
| Shares Outstanding | 252.81M | 252.80M | 252.81M | 256.60M | 281.00M |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 252.81M | 252.80M | 252.81M | 256.60M | 281.00M |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 252.81M | 252.80M | 280.82M | 280.82M | 281.35M |
| EBITDA | 21.00M | -148.00M | -100.00M | -93.00M | 5.00M |
| Tax Rate | 133.33% | -14.19% | -12.12% | -101.09% | 100.00% |